ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators with a diversified portfolio of therapeutic antibodies in cancers and auto-immunity. The Company develops two immunomodulator antibodies and is advancing several discovery programs on undisclosed targets, all playing a defined immune-modulating role in both innate and adaptive immunity.